CME Group Inc (CME)
Official siteFINANCIAL SERVICES • FINANCIAL DATA & STOCK EXCHANGES • NASDAQ
Market Cap: $113.81B
Last updated: Nov 17, 2026 at 11:05 AM ET
CME Group Inc (CME) Financials: Revenue, Profit and Cash Flow
CME Group reported revenue of $6.52B for the fiscal year ended Dec 31, 2025, up 6.4% from the year before. That year, net income was $4.07B with a net margin of 62.5%, operating cash flow was $4.28B and free cash flow was $4.19B. The quarter ended Sep 30, 2026 had revenue of $1.74B and net income of $1.04B.
Revenue and Margins
The operating margin was 64.9% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $3.60B, a compound annual rate of 6.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $6.52B | +6.4% | 86.1% | 64.9% | 62.5% |
| Dec 2024 | $6.13B | +9.9% | 86.1% | 64.1% | 57.5% |
| Dec 2023 | $5.58B | +11.1% | 85.1% | 61.6% | 57.8% |
| Dec 2022 | $5.02B | +7.0% | 85.0% | 60.1% | 53.6% |
| Dec 2021 | $4.69B | -4.0% | 82.2% | 56.4% | 56.2% |
| Dec 2020 | $4.88B | +0.3% | 82.5% | 54.0% | 43.1% |
| Dec 2019 | $4.87B | +13.0% | 81.5% | 53.2% | 86.9% |
| Dec 2018 | $4.31B | +18.2% | 81.7% | 60.5% | 45.5% |
| Dec 2017 | $3.64B | +1.4% | 84.5% | 63.4% | 111.5% |
| Dec 2016 | $3.60B | N/A | 84.9% | 61.2% | 42.7% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 15.3% from the year before. In the quarter ended Sep 2026, net income rose 14.5% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.52B | $6.13B | $5.58B | $5.02B | $4.69B | $4.88B | $4.87B | $4.31B | $3.64B | $3.60B |
| Cost of revenue | $907.00M | $850.30M | $828.60M | $753.10M | $837.00M | $856.50M | $898.70M | $789.40M | $563.90M | $543.20M |
| Gross profit | $5.61B | $5.28B | $4.75B | $4.27B | $3.85B | $4.03B | $3.97B | $3.52B | $3.08B | $3.05B |
| Operating income | $4.23B | $3.93B | $3.44B | $3.02B | $2.65B | $2.64B | $2.59B | $2.61B | $2.31B | $2.20B |
| Net income | $4.07B | $3.53B | $3.23B | $2.69B | $2.64B | $2.11B | $4.23B | $1.96B | $4.06B | $1.53B |
| EBITDA | N/A | N/A | N/A | N/A | $3.37B | $2.98B | N/A | N/A | N/A | $2.38B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.74B | $1.71B | $1.88B | $1.65B | $1.54B | $1.69B | $1.64B | $1.53B | $1.58B | $1.53B | $1.49B | $1.44B |
| Gross profit | $1.50B | $1.47B | $1.66B | $1.41B | $1.30B | $1.47B | $1.44B | $1.30B | $1.37B | $1.33B | $1.28B | $1.23B |
| Operating income | $1.14B | $1.11B | $1.31B | $1.02B | $972.60M | $1.13B | $1.11B | $947.10M | $1.02B | $1.00B | $959.60M | $863.20M |
| Net income | $1.04B | $1.04B | $1.15B | $1.18B | $908.00M | $1.03B | $956.20M | $874.60M | $912.80M | $883.20M | $855.20M | $814.60M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $3.48B by $938.80M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $198.42B | $137.45B | $129.71B | $174.18B | $196.78B | $124.66B | $75.22B | $77.48B | $75.79B | $69.37B |
| Current assets | $165.36B | $103.03B | $94.89B | $139.08B | $161.76B | $89.28B | $39.57B | $41.89B | $46.91B | $40.03B |
| Cash and equivalents | $4.42B | $2.89B | $2.91B | $2.72B | $2.83B | $1.63B | $1.55B | $1.37B | $1.90B | $1.87B |
| Total liabilities | $169.70B | $110.96B | $102.97B | $147.30B | $169.38B | $98.31B | $49.06B | $51.51B | $53.38B | $49.03B |
| Short-term debt | $55.80M | $749.80M | $0 | $16.00M | $749.40M | $0 | $49.70M | $574.20M | $0 | $37.54B |
| Long-term debt | $3.42B | $2.68B | $3.43B | $3.42B | $2.70B | $3.44B | $3.74B | $3.83B | $2.23B | $2.23B |
| Shareholder equity | $28.73B | $26.49B | $26.74B | $26.88B | $27.40B | $26.32B | $26.13B | $25.92B | $22.41B | $20.34B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $192.09B | $194.68B | $201.99B | $198.55B | $187.14B | $179.91B | $157.83B | $137.45B | $137.80B | $123.38B | $132.05B | $129.71B |
| Total liabilities | $165.53B | $168.16B | $175.38B | $169.82B | $158.95B | $152.17B | $130.80B | $110.96B | $109.58B | $95.74B | $104.90B | $102.97B |
| Cash and equivalents | $2.20B | $2.14B | $2.39B | $4.42B | $2.45B | $1.98B | $1.41B | $2.89B | $2.32B | $1.79B | $1.44B | $2.91B |
| Shareholder equity | $26.56B | $26.52B | $26.62B | $28.73B | $28.19B | $27.74B | $27.03B | $26.49B | $28.22B | $27.64B | $27.15B | $26.74B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 97.9% of operating cash flow. Dividends and share repurchases together came to 100.2% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.28B | $3.69B | $3.45B | $3.06B | $2.40B | $2.72B | $2.67B | $2.44B | -$1.75B | $1.73B |
| Capital expenditures | $83.50M | $94.00M | $76.40M | $89.70M | $127.20M | $197.50M | $245.60M | $116.70M | $81.90M | $91.80M |
| Free cash flow | $4.19B | $3.60B | $3.38B | $2.97B | $2.28B | $2.52B | $2.43B | $2.32B | -$1.83B | $1.64B |
| Dividends paid | $3.93B | $3.58B | $3.24B | $2.63B | $2.19B | $2.11B | $1.70B | $2.15B | $1.99B | $1.79B |
| Share repurchases | $266.10M | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | $1.50B | -$82.60M | $20.90M | -$489.80M | $58.40M | -$175.50M | -$152.60M | -$1.89B | $179.90M | $53.70M |
| Financing cash flow | $56.51B | $5.08B | -$48.34B | -$25.38B | $69.91B | $47.25B | -$4.72B | -$1.08B | -$1.99B | -$1.62B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.09B | $947.10M | $1.26B | $1.13B | $968.10M | $1.06B | $1.12B | $1.02B | $1.00B | $776.90M | $892.70M | $1.04B |
| Capital expenditures | $15.80M | $23.60M | $21.80M | $32.50M | $18.40M | $18.40M | $14.20M | $26.20M | $29.80M | $18.20M | $19.80M | $20.80M |
| Free cash flow | $1.07B | $923.50M | $1.24B | $1.10B | $949.70M | $1.04B | $1.10B | $991.70M | $973.20M | $758.70M | $872.90M | $1.02B |
Frequently Asked Questions About CME
What is CME Group's annual revenue?
CME Group reported revenue of $6.52B for the fiscal year ended Dec 31, 2025.
How fast is CME Group's revenue growing?
Revenue was up 6.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 9.1%.
Is CME Group profitable?
Yes. CME Group reported net income of $4.07B for the fiscal year ended Dec 31, 2025, with a net margin of 62.5%.
How much free cash flow does CME generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $4.28B minus capital expenditures of $83.50M produced free cash flow of $4.19B.
How much debt does CME Group have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $3.42B, short-term debt of $55.80M and cash and equivalents of $4.42B.
CME pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors